Obuhangire bwa Revvity (RVTY) bwa Sikaati
AI forecast: RVTY
AI ebandika ekiruho ky'obusobozi bw'omubere gw'ekiseera ekiddako, ekigero ky'omubere gw'ebirungi, n'ekigero ky'omubere gw'omwezi. Okuhinduka kuhakirizwa hakurikira obusobozi bwa nyuma. Bino ni obuhangire bw'obusobozi, si obuhangire bw'okuhanga.
Ebiharwa by'omwaka guhera mu myezi 6 eyita
Premium erikahyora ebyifujiraho by'AI eby'omutengo mu nsi y'omunzi omu, wiiki emu n'omwaka omu ku kizigirwa kino n'ebirala byonna.
Unlock Premium🔒 Ekihugho ky'obuhangire bw'obusobozi
Ekihugho ky'obuhangire bw'obusobozi — buli kihuugho ky'omubere gya nyuma hafi n'obusobozi bwa nyakuri — ni ekigero cya Premium.
Unlock PremiumEbikwata ku Kitongole Kino
Revvity, Inc. develops multi-omics technologies. Multi-omics is a comprehensive analytical approach in biology and medicine that assesses the interplay of various variables, including genomic, metabolomic, and other indicators. This approach enhances the understanding of biological processes, identifies biomarkers, delineates disease subtypes, and determines effective treatment and prevention strategies. In addition, the company provides information technology solutions to pharmaceutical and biotechnology companies. Revvity serves its customers in the United States.
